{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:42:56Z","timestamp":1791855776226,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05674-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:51:15Z","timestamp":1768528275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Methamphetamine-Driven Neuroinflammation and Parkinson\u2019s Disease Pathology: Mechanistic Insight into Nrf2 and NF\u0138B Signaling"],"prefix":"10.1007","volume":"63","author":[{"given":"Nileshwar","family":"Kalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1796-4913","authenticated-orcid":false,"given":"Omkar Kumar","family":"Kuwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"3","key":"5674_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.7150\/ijms.99159","volume":"22","author":"FF Ramli","year":"2025","unstructured":"Ramli FF et al (2025) A mechanistic review on toxicity effects of methamphetamine. Int J Med Sci 22(3):482","journal-title":"Int J Med Sci"},{"issue":"1","key":"5674_CR2","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1017\/S1092852925100357","volume":"30","author":"S Dodd","year":"2025","unstructured":"Dodd S, Ospina-Pinillos L, Markowitz JS (2025) Central nervous system stimulants in recreational and medical use. CNS Spectr 30(1):e52","journal-title":"CNS Spectr"},{"key":"5674_CR3","doi-asserted-by":"publisher","unstructured":"Paulus MP, Stewart JL (2020) Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: a review. JAMA Psychiatry 77(9):959\u2013966. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0246","DOI":"10.1001\/jamapsychiatry.2020.0246"},{"issue":"1","key":"5674_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11469-023-01134-7","volume":"23","author":"Z Cui","year":"2025","unstructured":"Cui Z, Norton A, Karamouzian M (2025) Characterizing methamphetamine use among people who use opioids: a systematic review. Int J Ment Health Addict 23(1):701\u2013749","journal-title":"Int J Ment Health Addict"},{"issue":"02","key":"5674_CR5","first-page":"192","volume":"3","author":"UT Ranjha","year":"2025","unstructured":"Ranjha UT, Awan HH, Khan F (2025) Investigating the physical effects of drug abuse on the human body. ASSAJ 3(02):192\u2013201","journal-title":"ASSAJ"},{"issue":"2","key":"5674_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.9758\/cpn.24.1236","volume":"23","author":"K Permpoonputtana","year":"2025","unstructured":"Permpoonputtana K et al (2025) Association of cognitive impairment and peripheral inflammation in methamphetamine-dependent patients: a cross-sectional study on neuroinflammatory markers TNF-\u03b1 and IL-6. Clin Psychopharmacol Neurosci 23(2):234","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"5674_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/nyas.15272","volume":"1543","author":"Z Yu","year":"2025","unstructured":"Yu Z et al (2025) The role of macroautophagy in substance use disorders. Ann N Y Acad Sci 1543(1):68\u201378","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"5674_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biom15020306","volume":"15","author":"R Khan","year":"2025","unstructured":"Khan R et al (2025) Genes, cognition, and their interplay in methamphetamine use disorder. Biomolecules 15(2):306","journal-title":"Biomolecules"},{"issue":"4","key":"5674_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/add.16695","volume":"120","author":"JM Lappin","year":"2025","unstructured":"Lappin JM (2025) Rare but relevant: methamphetamine and Parkinson\u2019s disease. Addiction 120(4):797\u2013800","journal-title":"Addiction"},{"issue":"5","key":"5674_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.69613\/ndgvdc46","volume":"3","author":"G Anusha","year":"2025","unstructured":"Anusha G et al (2025) Etiopathogenesis, clinical manifestations, and management of Parkinson\u2019s disease. Journal of Pharma Insights and Research 3(5):215\u2013224","journal-title":"J Pharma Insights Res"},{"key":"5674_CR11","unstructured":"Rinaldi D (2025) Motor and non-motor symptoms in advanced Parkinson\u2019s disease: current insights and future directions"},{"issue":"10","key":"5674_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/cells14100710","volume":"14","author":"I Beheshti","year":"2025","unstructured":"Beheshti I (2025) Exploring risk and protective factors in Parkinson\u2019s disease. Cells 14(10):710","journal-title":"Cells"},{"issue":"13","key":"5674_CR13","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.3390\/ijms26136416","volume":"26","author":"MS Khan","year":"2025","unstructured":"Khan MS, Nasiripour S, Bopassa JC (2025) Parkinson disease signaling pathways, molecular mechanisms, and potential therapeutic strategies: a comprehensive review. Int J Mol Sci 26(13):6416","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5674_CR14","doi-asserted-by":"publisher","first-page":"0070","DOI":"10.1079\/cabireviews.2025.0070","volume":"20","author":"R Sarkar","year":"2025","unstructured":"Sarkar R et al (2025) Exploring the environmental sources of Parkinson\u2019s disease and recent nanotechnological interventions in animal Parkinson models. CABI Reviews 20(1):0070","journal-title":"CABI Reviews"},{"key":"5674_CR15","doi-asserted-by":"crossref","unstructured":"Yesmin S et al (2025) Experimental models and behavioral parameters for evaluation of Parkinson disease. In: AIP Conference Proceedings. AIP Publishing LLC","DOI":"10.1063\/5.0272894"},{"issue":"1","key":"5674_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11469-023-01025-x","volume":"23","author":"SC Fang","year":"2025","unstructured":"Fang SC et al (2025) Influence of Baseline Psychiatric disorders on mortality and suicide and their associations with gender and age in patients with Methamphetamine Use Disorder. Int J Ment Heal Addict 23(1):263\u2013280","journal-title":"Int J Ment Heal Addict"},{"key":"5674_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-04034-3","author":"Y Huang","year":"2025","unstructured":"Huang Y et al (2025) Clinical outcomes of ocular syphilis within the Great Plains region: potential syndemic impact of methamphetamine use. Eye. https:\/\/doi.org\/10.1038\/s41433-025-04034-3","journal-title":"Eye"},{"issue":"1","key":"5674_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41531-025-01081-1","volume":"11","author":"JM Lababidi","year":"2025","unstructured":"Lababidi JM, Azzazy HMES (2025) Revamping Parkinson\u2019s disease therapy using PLGA-based drug delivery systems. NPJ Parkinsons Dis 11(1):248","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5674_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ejn.13363","volume":"45","author":"SJ Kish","year":"2017","unstructured":"Kish SJ et al (2017) Brain dopamine neurone \u2018damage\u2019: methamphetamine users vs. Parkinson\u2019s disease\u2013a critical assessment of the evidence. European journal of neuroscience 45(1):58\u201366","journal-title":"European journal of neuroscience"},{"key":"5674_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.phrs.2017.03.009","volume":"120","author":"MD Prakash","year":"2017","unstructured":"Prakash MD et al (2017) Methamphetamine: effects on the brain, gut and immune system. Pharmacol Res 120:60\u201367","journal-title":"Pharmacol Res"},{"issue":"Suppl 3","key":"5674_CR21","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.33549\/physiolres.934821","volume":"70","author":"B \u010cechov\u00e1","year":"2021","unstructured":"\u010cechov\u00e1 B, \u0160lamberov\u00e1 R (2021) Methamphetamine, neurotransmitters and neurodevelopment. Physiol Res 70(Suppl 3):S301","journal-title":"Physiol Res"},{"issue":"13","key":"5674_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2174\/1570159X21666230907151226","volume":"22","author":"B Vincent","year":"2024","unstructured":"Vincent B, Shukla M (2024) The common denominators of Parkinson\u2019s disease pathogenesis and methamphetamine abuse. Curr Neuropharmacol 22(13):2113\u20132156","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"5674_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11064-017-2318-5","volume":"43","author":"EJ Shin","year":"2018","unstructured":"Shin EJ et al (2018) Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis\u2014a review. Neurochem Res 43(1):66\u201378","journal-title":"Neurochem Res"},{"issue":"5","key":"5674_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4062\/biomolther.2020.044","volume":"28","author":"B Kim","year":"2020","unstructured":"Kim B, Yun J, Park B (2020) Methamphetamine-induced neuronal damage: neurotoxicity and neuroinflammation. Biomol Ther (Seoul) 28(5):381","journal-title":"Biomol Ther (Seoul)"},{"issue":"5","key":"5674_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/joim.12049","volume":"273","author":"S Ares-Santos","year":"2013","unstructured":"Ares-Santos S, Granado N, Moratalla R (2013) The role of dopamine receptors in the neurotoxicity of methamphetamine. J Intern Med 273(5):437\u2013453","journal-title":"J Intern Med"},{"issue":"7","key":"5674_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J et al (2021) Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res 16(7):1383\u20131391","journal-title":"Neural Regen Res"},{"issue":"4","key":"5674_CR27","first-page":"414","volume":"83","author":"S Omidvari","year":"2023","unstructured":"Omidvari S et al (2023) Molecular mechanisms and treatment strategies for methamphetamine-induced neurodegeneration, inflammation and neurotoxicity. Acta Neurobiol Exp 83(4):414\u2013431","journal-title":"Acta Neurobiol Exp"},{"key":"5674_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0074-7742(09)88003-3","volume":"88","author":"T Kita","year":"2009","unstructured":"Kita T et al (2009) Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 88:43\u201364","journal-title":"Int Rev Neurobiol"},{"key":"5674_CR29","doi-asserted-by":"publisher","first-page":"585584","DOI":"10.3389\/fnins.2020.585584","volume":"14","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020) Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease. Front Neurosci 14:585584","journal-title":"Front Neurosci"},{"issue":"7","key":"5674_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12272-021-01341-7","volume":"44","author":"EJ Shin","year":"2021","unstructured":"Shin EJ et al (2021) Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson\u2019s disease. Arch Pharm Res 44(7):668\u2013688","journal-title":"Arch Pharm Res"},{"issue":"4","key":"5674_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12640-020-00177-1","volume":"37","author":"AL Pan","year":"2020","unstructured":"Pan AL et al (2020) Epigallocatechin gallate mitigates the methamphetamine-induced striatal dopamine terminal toxicity by preventing oxidative stress in the mouse brain. Neurotox Res 37(4):883\u2013892","journal-title":"Neurotox Res"},{"issue":"1","key":"5674_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/ijms23010363","volume":"23","author":"V Bazylianska","year":"2021","unstructured":"Bazylianska V et al (2021) Dopamine and methamphetamine differentially affect electron transport chain complexes and parkin in rat striatum: new insight into methamphetamine neurotoxicity. Int J Mol Sci 23(1):363","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5674_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10(3):200","journal-title":"AIMS Neurosci"},{"issue":"1","key":"5674_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1742-2094-9-103","volume":"9","author":"V Coelho-Santos","year":"2012","unstructured":"Coelho-Santos V et al (2012) Prevention of methamphetamine-induced microglial cell death by TNF-\u03b1 and IL-6 through activation of the JAK-STAT pathway. J Neuroinflammation 9(1):103","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5674_CR35","doi-asserted-by":"publisher","first-page":"20221051","DOI":"10.1515\/biol-2022-1051","volume":"20","author":"S Huang","year":"2025","unstructured":"Huang S et al (2025) Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sci 20(1):20221051","journal-title":"Open Life Sci"},{"issue":"9","key":"5674_CR36","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/toxics13090736","volume":"13","author":"P Zhou","year":"2025","unstructured":"Zhou P et al (2025) Methamphetamine exposure induces neuronal programmed necrosis by permeabilizing mitochondria via the RIPK1\u2013RIPK3\u2013MLKL axis. Toxics 13(9):736","journal-title":"Toxics"},{"issue":"7","key":"5674_CR37","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/biom15070958","volume":"15","author":"A Sharma","year":"2025","unstructured":"Sharma A et al (2025) The proteomic landscape of Parkin-deficient and Parkin-overexpressing rat nucleus accumbens: an insight into the role of Parkin in methamphetamine use disorder. Biomolecules 15(7):958","journal-title":"Biomolecules"},{"key":"5674_CR38","doi-asserted-by":"crossref","unstructured":"Hashemi M et al (2025) Apoptosis: basics and role in pathological diseases. In: Autophagy, Apoptosis and Ferroptosis in Oncology: cell death and cancer. World Scientific, pp 265\u2013315","DOI":"10.1142\/9789811299322_0010"},{"issue":"1","key":"5674_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/09540105.2020.1784099","volume":"31","author":"Q Xiong","year":"2020","unstructured":"Xiong Q et al (2020) Sulforaphane alleviates methamphetamine-induced oxidative damage and apoptosis via the Nrf2-mediated pathway in vitro and in vivo. Food Agric Immunol 31(1):859\u2013880","journal-title":"Food Agric Immunol"},{"issue":"1","key":"5674_CR40","doi-asserted-by":"publisher","first-page":"8400876","DOI":"10.1155\/2022\/8400876","volume":"2022","author":"J Huang","year":"2022","unstructured":"Huang J et al (2022) Icariside II attenuates methamphetamine-induced neurotoxicity and behavioral impairments via activating the Keap1-Nrf2 pathway. Oxid Med Cell Longev 2022(1):8400876","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"5674_CR41","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s11064-015-1613-2","volume":"40","author":"P Jumnongprakhon","year":"2015","unstructured":"Jumnongprakhon P et al (2015) Melatonin protects methamphetamine-induced neuroinflammation through NF-\u03baB and Nrf2 pathways in glioma cell line. Neurochem Res 40(7):1448\u20131456","journal-title":"Neurochem Res"},{"issue":"3","key":"5674_CR42","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/jpet.102.045005","volume":"304","author":"V Sandoval","year":"2003","unstructured":"Sandoval V et al (2003) Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. J Pharmacol Exp Ther 304(3):1181\u20131187","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"5674_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/npp.2017.291","volume":"43","author":"DM Hedges","year":"2018","unstructured":"Hedges DM et al (2018) Methamphetamine induces dopamine release in the nucleus accumbens through a sigma receptor-mediated pathway. Neuropsychopharmacology 43(6):1405\u20131414","journal-title":"Neuropsychopharmacology"},{"key":"5674_CR44","doi-asserted-by":"publisher","unstructured":"Zhu BT (2025) Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-Hydroxydopamine) and \u03b1-synuclein: a unifying hypothesis. J Mol Cell Biol mjaf041. https:\/\/doi.org\/10.1093\/jmcb\/mjaf041","DOI":"10.1093\/jmcb\/mjaf041"},{"issue":"9","key":"5674_CR45","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1007\/s10787-025-01846-3","volume":"33","author":"K Mahto","year":"2025","unstructured":"Mahto K et al (2025) Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF\u0138B, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis. Inflammopharmacology 33(9):5011\u20135021","journal-title":"Inflammopharmacology"},{"key":"5674_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01698-x","author":"OK Kuwar","year":"2025","unstructured":"Kuwar OK, Kalia N (2025) Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF\u0138B in neurodegenerative disease. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01698-x","journal-title":"Inflammopharmacology"},{"issue":"15","key":"5674_CR47","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.3390\/ijms26157520","volume":"26","author":"CF Manful","year":"2025","unstructured":"Manful CF et al (2025) Antioxidants and reactive oxygen species: shaping human health and disease outcomes. Int J Mol Sci 26(15):7520","journal-title":"Int J Mol Sci"},{"key":"5674_CR48","doi-asserted-by":"publisher","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(21) . https:\/\/doi.org\/10.1007\/s10048-025-00801-2","DOI":"10.1007\/s10048-025-00801-2"},{"issue":"9","key":"5674_CR49","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/cimb47090710","volume":"47","author":"DI Cherneva","year":"2025","unstructured":"Cherneva DI et al (2025) The central nervous system modulatory activities of N-acetylcysteine: a synthesis of two decades of evidence. Curr Issues Mol Biol 47(9):710","journal-title":"Curr Issues Mol Biol"},{"issue":"8","key":"5674_CR50","doi-asserted-by":"publisher","first-page":"e70041","DOI":"10.1096\/fba.2025-00093","volume":"7","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) Unraveling the vicious cycle: oxidative stress and neurotoxicity in neurodegenerative diseases. FASEB Bioadv 7(8):e70041","journal-title":"FASEB Bioadv"},{"key":"5674_CR51","doi-asserted-by":"publisher","first-page":"911060","DOI":"10.3389\/fncel.2022.911060","volume":"16","author":"LV Basova","year":"2022","unstructured":"Basova LV et al (2022) Methamphetamine signals transcription of IL1\u03b2 and TNF\u03b1 in a reactive oxygen species-dependent manner and interacts with HIV-1 Tat to decrease antioxidant defense mechanisms. Front Cell Neurosci 16:911060","journal-title":"Front Cell Neurosci"},{"key":"5674_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01839-2","author":"OK Kuwar","year":"2025","unstructured":"Kuwar OK, Singh S (2025) Baicalein-mediated regulation of Nrf2\/ARE, NF\u0138B, and MAPK signaling in Huntington\u2019s disease: a promising strategy against neuroinflammation and neurodegeneration. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01839-2","journal-title":"Inflammopharmacology"},{"issue":"12","key":"5674_CR53","doi-asserted-by":"publisher","first-page":"BSR20211191","DOI":"10.1042\/BSR20211191","volume":"41","author":"G Assis-de-Lemos","year":"2021","unstructured":"Assis-de-Lemos G et al (2021) Dopamine signaling impairs ROS modulation by mitochondrial hexokinase in human neural progenitor cells. Biosci Rep 41(12):BSR20211191. https:\/\/doi.org\/10.1042\/BSR20211191","journal-title":"Biosci Rep"},{"key":"5674_CR54","volume-title":"Understanding the assembly of an IKK complex in classical NF-kappaB signaling pathway using HDX-MS","author":"W Suryajaya","year":"2022","unstructured":"Suryajaya W (2022) Understanding the assembly of an IKK complex in classical NF-kappaB signaling pathway using HDX-MS. University of California, San Diego"},{"issue":"2","key":"5674_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"I Babkina","year":"2021","unstructured":"Babkina I, Sergeeva S, Gorbacheva L (2021) The role of NF-\u03baB in neuroinflammation. Neurochem J 15(2):114\u2013128","journal-title":"Neurochem J"},{"issue":"8","key":"5674_CR56","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/jcbfm.2015.59","volume":"35","author":"V Coelho-Santos","year":"2015","unstructured":"Coelho-Santos V et al (2015) The TNF-\u03b1\/Nf-\u03ba B signaling pathway has a key role in methamphetamine\u2013induced blood\u2013brain barrier dysfunction. J Cereb Blood Flow Metab 35(8):1260\u20131271","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"5674_CR57","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s12035-020-02184-x","volume":"58","author":"ET Chivero","year":"2021","unstructured":"Chivero ET et al (2021) NLRP3 inflammasome blockade reduces cocaine-induced microglial activation and neuroinflammation. Mol Neurobiol 58(5):2215\u20132230","journal-title":"Mol Neurobiol"},{"key":"5674_CR58","doi-asserted-by":"publisher","first-page":"1624770","DOI":"10.3389\/fimmu.2025.1624770","volume":"16","author":"MV Pinz\u00f3n-Fern\u00e1ndez","year":"2025","unstructured":"Pinz\u00f3n-Fern\u00e1ndez MV et al (2025) NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease. Front Immunol 16:1624770","journal-title":"Front Immunol"},{"issue":"9","key":"5674_CR59","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1007\/s10787-025-01912-w","volume":"33","author":"K Mahto","year":"2025","unstructured":"Mahto K et al (2025) Therapeutic potential of Boswellia serrata in arthritis management: mechanistic insights into COX-2, 5-LOX, and NF\u0138B modulation. Inflammopharmacology 33(9):5085\u20135096","journal-title":"Inflammopharmacology"},{"issue":"8-9","key":"5674_CR60","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/10715762.2025.2565686","volume":"59","author":"SK Pandey","year":"2025","unstructured":"Pandey SK et al (2025) Betulinic acid protects SH-SY5Y cells exposed to lipopolysaccharide and ferrous sulfate through p38MAPK\/NF-\u03baB\/GPX4\/Nrf2\/keap-1\/HO-1 signaling axis. Free Radic Res 59(8\u20139):688\u2013706","journal-title":"Free Radic Res"},{"issue":"1","key":"5674_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12035-025-05313-6","volume":"63","author":"M Attri","year":"2026","unstructured":"Attri M, Kuwar OK (2026) The KEAP1-Cullin3-RBX1-Nrf2 axis in redox homeostasis: molecular mechanisms, pathophysiological roles, and precision therapeutic opportunities. Mol Neurobiol 63(1):15","journal-title":"Mol Neurobiol"},{"key":"5674_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.toxlet.2023.08.002","volume":"384","author":"W Dong","year":"2023","unstructured":"Dong W et al (2023) Nrf2 protects against methamphetamine-induced nephrotoxicity by mitigating oxidative stress and autophagy in mice. Toxicol Lett 384:136\u2013148","journal-title":"Toxicol Lett"},{"issue":"3","key":"5674_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176","journal-title":"Cell Death Dis"},{"issue":"1","key":"5674_CR64","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ijms25010360","volume":"25","author":"K Saramowicz","year":"2023","unstructured":"Saramowicz K et al (2023) Alpha-synuclein contribution to neuronal and glial damage in Parkinson\u2019s disease. Int J Mol Sci 25(1):360","journal-title":"Int J Mol Sci"},{"key":"5674_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2025.111826","author":"JJ Rijnhart","year":"2025","unstructured":"Rijnhart JJ et al (2025) An umbrella review reveals that control variables are rarely considered as a source of heterogeneity in systematic reviews of observational studies. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111826","journal-title":"J Clin Epidemiol"},{"key":"5674_CR66","doi-asserted-by":"publisher","unstructured":"Tunagur MT, Kurt Tunagur EM (2025) Systemic inflammatory indices as biomarkers in adolescents with methamphetamine use disorder: a case-control study. J Addict Dis 1\u201310.\u00a0https:\/\/doi.org\/10.1080\/10550887.2025.2595156","DOI":"10.1080\/10550887.2025.2595156"},{"issue":"5","key":"5674_CR67","doi-asserted-by":"publisher","first-page":"e0323761","DOI":"10.1371\/journal.pone.0323761","volume":"20","author":"MP Gorenflo","year":"2025","unstructured":"Gorenflo MP et al (2025) Amphetamine use and Parkinson\u2019s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses. PLoS ONE 20(5):e0323761","journal-title":"PLoS ONE"},{"issue":"5","key":"5674_CR68","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1007\/s11469-024-01333-w","volume":"23","author":"M Fritz","year":"2025","unstructured":"Fritz M et al (2025) Unraveling relapse in male forensic psychiatric patients with substance use disorders\u2014the impact of social, psychiatric, and personality factors post long-term remission. Int J Ment Heal Addict 23(5):3988\u20134003","journal-title":"Int J Ment Heal Addict"},{"key":"5674_CR69","doi-asserted-by":"publisher","unstructured":"Jaakkola E, Koponen M, Kaasinen V, Hietala J, Hartikainen S, Tolppanen AM (2025) Bipolar disorder as a long-term risk factor for parkinson's disease: a nationwide case-control study. Mov Disord 70135.\u00a0https:\/\/doi.org\/10.1002\/mds.70135","DOI":"10.1002\/mds.70135"},{"key":"5674_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2025.04.015","author":"H Liao","year":"2025","unstructured":"Liao H et al (2025) Epigenetic effects of paternal environmental exposures and experiences on offspring phenotypes. Trends Genet. https:\/\/doi.org\/10.1016\/j.tig.2025.04.015","journal-title":"Trends Genet"},{"key":"5674_CR71","doi-asserted-by":"publisher","first-page":"1604252","DOI":"10.3389\/fpsyt.2025.1604252","volume":"16","author":"MF Vest","year":"2025","unstructured":"Vest MF et al (2025) Individuals recently abstinent from methamphetamine show selective cognitive and behavioral differences when compared to age-matched controls. Front Psychiatry 16:1604252","journal-title":"Front Psychiatry"},{"key":"5674_CR72","doi-asserted-by":"publisher","first-page":"112280","DOI":"10.1016\/j.cellsig.2025.112280","volume":"138","author":"Y Li","year":"2026","unstructured":"Li Y et al (2026) Cannabidiol alleviates methamphetamine-induced autophagy and oxidative stress by suppressing sigma 1 receptor expression. Cell Signal 138:112280","journal-title":"Cell Signal"},{"issue":"12","key":"5674_CR73","doi-asserted-by":"publisher","first-page":"e0336614","DOI":"10.1371\/journal.pone.0336614","volume":"20","author":"NL Ndlovu","year":"2025","unstructured":"Ndlovu NL et al (2025) Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016\u20132017. PLoS ONE 20(12):e0336614","journal-title":"PLoS ONE"},{"issue":"10423","key":"5674_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y et al (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292","journal-title":"Lancet"},{"key":"5674_CR75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.drugalcdep.2018.02.032","volume":"187","author":"JM Lappin","year":"2018","unstructured":"Lappin JM, Darke S, Farrell M (2018) Methamphetamine use and future risk for Parkinson\u2019s disease: evidence and clinical implications. Drug Alcohol Depend 187:134\u2013140","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5674_CR76","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s12640-021-00332-2","volume":"39","author":"M Wu","year":"2021","unstructured":"Wu M, Su H, Zhao M (2021) The role of \u03b1-synuclein in methamphetamine-induced neurotoxicity. Neurotox Res 39(3):1007\u20131021","journal-title":"Neurotox Res"},{"issue":"1","key":"5674_CR77","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","volume":"9","author":"M Tsalenchuk","year":"2023","unstructured":"Tsalenchuk M, Gentleman SM, Marzi SJ (2023) Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):123","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"5674_CR78","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0269881106059939","volume":"20","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Daumann J (2006) The confounding problem of polydrug use in recreational ecstasy\/MDMA users: a brief overview. J Psychopharmacol 20(2):188\u2013193","journal-title":"J Psychopharmacol"},{"key":"5674_CR79","doi-asserted-by":"publisher","first-page":"1248727","DOI":"10.3389\/fnins.2023.1248727","volume":"17","author":"C Sanfeliu","year":"2024","unstructured":"Sanfeliu C et al (2024) New insights in animal models of neurotoxicity-induced neurodegeneration. Front Neurosci 17:1248727","journal-title":"Front Neurosci"},{"issue":"Suppl 1","key":"5674_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1289\/ehp.96104s155","volume":"104","author":"LG Costa","year":"1996","unstructured":"Costa LG (1996) Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ Health Perspect 104(Suppl 1):55","journal-title":"Environ Health Perspect"},{"issue":"3","key":"5674_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1254\/jphs.92.178","volume":"92","author":"T Kita","year":"2003","unstructured":"Kita T, Wagner GC, Nakashima T (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92(3):178\u2013195","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"5674_CR82","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/brainsci12060779","volume":"12","author":"A Kolacheva","year":"2022","unstructured":"Kolacheva A et al (2022) Changes in tyrosine hydroxylase activity and dopamine synthesis in the nigrostriatal system of mice in an acute model of Parkinson\u2019s disease as a manifestation of neurodegeneration and neuroplasticity. Brain Sci 12(6):779","journal-title":"Brain Sci"},{"issue":"9","key":"5674_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","volume":"30","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30(9):475\u2013483","journal-title":"Trends Pharmacol Sci"},{"key":"5674_CR84","doi-asserted-by":"publisher","unstructured":"Meng Y, Qiao H, Ding J, He Y, Fan H, Li C, Qiu P (2020) Effect of Parkin on methamphetamine-induced \u03b1-synuclein degradation dysfunction in vitro and in vivo. Brain Behav 10(4):e01574.\u00a0https:\/\/doi.org\/10.1002\/brb3.1574","DOI":"10.1002\/brb3.1574"},{"key":"5674_CR85","doi-asserted-by":"publisher","unstructured":"Zhou Y, Hong Q, Xu W, Chen S, Du H, Xie X, Lai M, Chen W, Zhou W, Si Z, Liu H (2025) tRF-M2-regulated dopamine receptor d2 expression attenuates methamphetamine reinstatement behavior in rats. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/nyas.70127","DOI":"10.1111\/nyas.70127"},{"key":"5674_CR86","doi-asserted-by":"publisher","first-page":"105409","DOI":"10.1016\/j.nbd.2021.105409","volume":"156","author":"SM Graves","year":"2021","unstructured":"Graves SM et al (2021) Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons. Neurobiol Dis 156:105409","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5674_CR87","first-page":"713517","volume":"2011","author":"D Litteljohn","year":"2011","unstructured":"Litteljohn D et al (2011) Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2032 s disease. Parkinson\u2019s disease 2011(1):713517","journal-title":"Parkinson\u2019s disease"},{"key":"5674_CR88","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.biopha.2022.113591","volume":"154","author":"P Shrestha","year":"2022","unstructured":"Shrestha P et al (2022) Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies. Biomed Pharmacother 154:113591","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5674_CR89","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/15569543.2024.2360425","volume":"43","author":"SK Rashidi","year":"2024","unstructured":"Rashidi SK et al (2024) Methamphetamine and the brain: emerging molecular targets and signaling pathways involved in neurotoxicity. Toxin Rev 43(4):553\u2013571","journal-title":"Toxin Rev"},{"issue":"2","key":"5674_CR90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF02854914","volume":"8","author":"EL Riddle","year":"2006","unstructured":"Riddle EL, Fleckenstein AE, Hanson GR (2006) Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 8(2):48","journal-title":"AAPS J"},{"key":"5674_CR91","doi-asserted-by":"publisher","unstructured":"Rasool A, Manzoor R, Ullah K, Afzal R, Ul-Haq A, Imran H, Kaleem I, Akhtar T, Farrukh A, Hameed S, Bashir S (2024) Oxidative stress and dopaminergic metabolism: a major pd pathogenic mechanism and basis of potential antioxidant therapies. CNS Neurol Disord Drug Targets 23(7):852\u2013864. https:\/\/doi.org\/10.2174\/1871527322666230609141519","DOI":"10.2174\/1871527322666230609141519"},{"key":"5674_CR92","unstructured":"Engwa GA, Nweke FN, Nkeh-Chungag BN (2022) Free radicals, oxidative stress-related diseases and antioxidant supplementation. Altern Ther Health Med 28(1):114\u2013128"},{"issue":"20","key":"5674_CR93","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1002\/anie.201811122","volume":"58","author":"E Monzani","year":"2019","unstructured":"Monzani E et al (2019) Dopamine, oxidative stress and protein\u2013quinone modifications in Parkinson\u2019s and other neurodegenerative diseases. Angew Chem Int Ed Engl 58(20):6512\u20136527","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"5674_CR94","first-page":"1817","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo JD et al (2018) Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease. Int J Mol Med 41(4):1817\u20131825","journal-title":"Int J Mol Med"},{"issue":"4","key":"5674_CR95","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11064-021-03513-9","volume":"47","author":"S Shi","year":"2022","unstructured":"Shi S, Chen T, Zhao M (2022) The crosstalk between neurons and glia in methamphetamine-induced neuroinflammation. Neurochem Res 47(4):872\u2013884","journal-title":"Neurochem Res"},{"key":"5674_CR96","doi-asserted-by":"publisher","unstructured":"Shi S, Chen T, Zhao M (2022) The crosstalk between neurons and glia in methamphetamine-induced neuroinflammation. Neurochem Res 47(4):872\u2013884.\u00a0https:\/\/doi.org\/10.1007\/s11064-021-03513-9","DOI":"10.1007\/s11064-021-03513-9"},{"issue":"5","key":"5674_CR97","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.4049\/jimmunol.0903691","volume":"185","author":"R Potula","year":"2010","unstructured":"Potula R et al (2010) Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J Immunol 185(5):2867\u20132876","journal-title":"J Immunol"},{"key":"5674_CR98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease. Front Comput Neurosci 7:13","journal-title":"Front Comput Neurosci"},{"key":"5674_CR99","doi-asserted-by":"publisher","unstructured":"Kuwar OK, Dhingra MS, Maloo A et al (2026) The interplay between inflammation and oxidative stress in depression: pathogenic mechanisms and treatment approaches. Mol Biol Rep 53(239). https:\/\/doi.org\/10.1007\/s11033-025-11393-3","DOI":"10.1007\/s11033-025-11393-3"},{"issue":"1","key":"5674_CR100","doi-asserted-by":"publisher","first-page":"4982453","DOI":"10.1155\/2018\/4982453","volume":"2018","author":"F Limanaqi","year":"2018","unstructured":"Limanaqi F et al (2018) Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress. Oxid Med Cell Longev 2018(1):4982453","journal-title":"Oxid Med Cell Longev"},{"key":"5674_CR101","doi-asserted-by":"publisher","first-page":"1494557","DOI":"10.3389\/fcell.2024.1494557","volume":"12","author":"M Liu","year":"2024","unstructured":"Liu M, Si Z (2024) An update: epigenetic mechanisms underlying methamphetamine addiction. Front Cell Dev Biol 12:1494557","journal-title":"Front Cell Dev Biol"},{"issue":"16","key":"5674_CR102","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.3390\/ijms20163896","volume":"20","author":"E L\u00e9vy","year":"2019","unstructured":"L\u00e9vy E et al (2019) Causative links between protein aggregation and oxidative stress: a review. Int J Mol Sci 20(16):3896","journal-title":"Int J Mol Sci"},{"key":"5674_CR103","first-page":"1","volume":"146","author":"C Selvaraj","year":"2025","unstructured":"Selvaraj C et al (2025) Proteostasis imbalance: unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies. Adv Protein Chem Struct Biol 146:1\u201334","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"3","key":"5674_CR104","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/med.22091","volume":"45","author":"G Bellini","year":"2025","unstructured":"Bellini G et al (2025) \u03b1-Synuclein in Parkinson\u2019s disease: from bench to bedside. Med Res Rev 45(3):909\u2013946","journal-title":"Med Res Rev"},{"issue":"2","key":"5674_CR105","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/17568919.2024.2447226","volume":"17","author":"N Jeffery","year":"2025","unstructured":"Jeffery N et al (2025) Therapeutic targeting of neuroinflammation in methamphetamine use disorder. Future Med Chem 17(2):237\u2013257","journal-title":"Future Med Chem"},{"key":"5674_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-025-02197-5","author":"R Zhang","year":"2025","unstructured":"Zhang R et al (2025) L. johnsonii alleviates methamphetamine craving via the metabolism of tyrosine. Microbiome. https:\/\/doi.org\/10.1186\/s40168-025-02197-5","journal-title":"Microbiome"},{"issue":"6","key":"5674_CR107","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/RPS.RPS_55_25","volume":"20","author":"A Reihani","year":"2025","unstructured":"Reihani A et al (2025) Sulforaphane attenuates oxidative stress, senescence, and ferroptosis induced by cigarette smoke extract in vitro and in vivo via upregulating the expression of SIRT1. Res Pharm Sci 20(6):853\u2013865","journal-title":"Res Pharm Sci"},{"issue":"1","key":"5674_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-025-00821-y","volume":"26","author":"K Abbas","year":"2025","unstructured":"Abbas K et al (2025) Multi-target approach to Alzheimer\u2019s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid-modulating mechanisms. Neurogenetics 26(1):1\u201320","journal-title":"Neurogenetics"},{"key":"5674_CR109","doi-asserted-by":"publisher","first-page":"110790","DOI":"10.1016\/j.neuropharm.2025.110790","volume":"285","author":"S Fallahi","year":"2025","unstructured":"Fallahi S et al (2025) Exosome therapy protects the hippocampus in mice exposed to chronic methamphetamine: Insights into angiogenic and inflammatory signaling pathways. Neuropharmacology 285:110790","journal-title":"Neuropharmacology"},{"issue":"1","key":"5674_CR110","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/med.21732","volume":"41","author":"AS Manolis","year":"2021","unstructured":"Manolis AS et al (2021) Mitochondrial dysfunction in cardiovascular disease: current status of translational research\/clinical and therapeutic implications. Med Res Rev 41(1):275\u2013313","journal-title":"Med Res Rev"},{"issue":"1","key":"5674_CR111","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00018-025-05890-8","volume":"82","author":"AF Terceiro","year":"2025","unstructured":"Terceiro AF et al (2025) Intersectin1\/cdc42 signaling regulates methamphetamine-induced neuronal remodeling in the hippocampus. Cell Mol Life Sci 82(1):387","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5674_CR112","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12035-025-05382-7","volume":"63","author":"T Mohtashami","year":"2025","unstructured":"Mohtashami T et al (2025) Neuroprotective effects of platelet-derived exosomes in a rat model of methamphetamine-induced neurotoxicity. Mol Neurobiol 63(1):59","journal-title":"Mol Neurobiol"},{"issue":"23","key":"5674_CR113","doi-asserted-by":"publisher","first-page":"25469","DOI":"10.1021\/acs.jmedchem.5c02596","volume":"68","author":"J Gao","year":"2025","unstructured":"Gao J et al (2025) Nanomolar TLR4 antagonist CIAC101 derived from (+)-Naltrexone blocks microglial activation and methamphetamine addiction. J Med Chem 68(23):25469\u201325484","journal-title":"J Med Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05674-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05674-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05674-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:02:49Z","timestamp":1768572169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05674-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5674"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05674-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"365"}}